Results 171 to 180 of about 10,432 (237)

Hormonal Contraceptive Formulations and Breast Cancer Risk in Adolescents and Premenopausal Women. [PDF]

JAMA Oncol
Hadizadeh F, Koteci A, Karlsson T, Ek WE, Johansson Å.   +4 more
europepmc   +1 more source

Establishing a Quantitative Framework for Combined Oral Contraceptives: Evaluating the Impact of Drug-Drug Interactions on Exposure and Clinical (Surrogate) Efficacy Endpoints. [PDF]

J Clin Pharmacol
Chun D, Chen H, Cicali B, Guzy S, Hoechel J, Jiao T, Vozmediano V, Schmidt S.   +7 more
europepmc   +1 more source

Elagolix as a Diagnostic and Therapeutic Bridge to Surgery in Refractory Progestogen Hypersensitivity. [PDF]

JCEM Case Rep
Balkan AO, Sistla D, Rhinehart EL.
europepmc   +1 more source

Pathophysiological Consequences Associated with Hormonal Contraceptives Use in Sub-Saharan Africa: A Scoping Review. [PDF]

Open Access J Contracept
Kampire MG, Hakizimana JC, Mucumbitsi J, Alagbonsi AI.   +3 more
europepmc   +1 more source

Review of hormonal replacement therapy options for the treatments of menopausal symptoms. [PDF]

Korean J Fam Med
Edelweishia M, Christoper A, Theresia E, Angelia V.   +3 more
europepmc   +1 more source

Insights on Medical Therapy for Uterine Fibroids: A Review. [PDF]

Adv Ther
Pecorella G, Morciano A, Sparic R, Hatirnaz S, Medvediev M, Malvasi A, Damiani GR, Tinelli A.   +7 more
europepmc   +1 more source

Understanding Peritoneal Fluid Estrogen and Progesterone Concentrations Permits Individualization of Medical Treatment of Endometriosis-Associated Pain with Lower Doses, Especially in Adolescents Not Requiring Contraception. [PDF]

J Clin Med
Koninckx PR, Ussia A, Adamyan L, Wattiez A, Vigano P.   +4 more
europepmc   +1 more source

Medroxyprogesterone Acetate Inhibits Tumorigenesis in Mouse Models of Oviductal High-Grade Serous Carcinoma. [PDF]

Cancers (Basel)
Zhai Y, Bedi K, Wu R, Feng Y, Green ME, Pearce CL, Pike MC, Fearon ER, Cho KR.   +8 more
europepmc   +1 more source